Drew Mathew Fehsenfeld, MD

NPI 1124137112ActiveIndividual· Orthopaedic Surgery· Houston, TX

Orthopaedic Surgery (MD) in Houston, Texas, trained at University of Texas Medical School at San Antonio (class of 2003). 292 Medicare patients in 2024, $100,829 paid; all of their 193 Part D prescriptions were generic. Vertex Pharmaceuticals Incorporated was the largest of 2 companies reporting payments in 2025, $53.67 in all, mostly food and beverage.

Overview

NPI	1124137112
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Aug 30, 2006
Last updated in NPPES	Feb 4, 2026
Certified by provider	Feb 4, 2026

Specialties and licenses

Taxonomy	Code	License	State
Orthopaedic Surgery Primary	207X00000X	N2496	TX
Orthopaedic Surgery, Sports Medicine	207XX0005X	N2496	TX

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Sports Medicine (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	292
Services billed	12,574 across 70 procedure codes
Paid by Medicare	$100,829

Part D prescriptions in 2024

Prescriptions (claims)	193 · 194 30-day fills
Patients	118
Total drug cost	$1,455
Generic share	100% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Medical School at San Antonio
Graduation year	2003
Medicare specialty	Sports Medicine
Secondary specialties	Orthopedic Surgery